Alteration of the faecal microbiota composition in patients with constipation: evidence of American Gut Project.

IF 3 4区 医学 Q2 MICROBIOLOGY
Beneficial microbes Pub Date : 2022-12-07 Epub Date: 2022-11-15 DOI:10.3920/BM2022.0009
Y S Xu, Y H Wang, Y Liu, X Sun, J S Xu, Y Song, X Jiang, Z F Xiong, Z B Tian, C P Zhang
{"title":"Alteration of the faecal microbiota composition in patients with constipation: evidence of American Gut Project.","authors":"Y S Xu, Y H Wang, Y Liu, X Sun, J S Xu, Y Song, X Jiang, Z F Xiong, Z B Tian, C P Zhang","doi":"10.3920/BM2022.0009","DOIUrl":null,"url":null,"abstract":"<p><p>There is limited information is known about the composition difference of the gut microbiota in patients with constipation and healthy controls. Here, the faecal 16S rRNA fastq sequence data of microbiota from the publicly available American Gut Project (AGP) were analysed. The tendency score matching (PSM) method was used to match in a 1:1 manner to control for confounding factors age, gender, body mass index (BMI), and country. A total of 524 participants including 262 patients with constipation and 262 healthy controls were included in this analysis. The richness and evenness of the gut microbiota in the constipation group were significantly lower than those in the control group. The dominant genera in the constipation group include <i>Escherichia_Shigella</i>, <i>Pseudomonas,</i> and <i>Citrobacter.</i> The dominant genera in the control group include <i>Faecalibacterium, Prevotella, Roseburia, Clostridium_XlVa,</i> and <i>Blautia</i>. The abundance of three butyrate production-related pathways were significantly higher in the constipation group than in the control groups. There was no significant difference in the diversity and gut microbiota composition in patients with constipation at different ages. In conclusion, patients with constipation showed gut microbiota and butyrate metabolism dysbiosis. This dysbiosis might provide a reference for the diagnosis and clinical therapy of diseases.</p>","PeriodicalId":8834,"journal":{"name":"Beneficial microbes","volume":"13 6","pages":"427-436"},"PeriodicalIF":3.0000,"publicationDate":"2022-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Beneficial microbes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3920/BM2022.0009","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/11/15 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

There is limited information is known about the composition difference of the gut microbiota in patients with constipation and healthy controls. Here, the faecal 16S rRNA fastq sequence data of microbiota from the publicly available American Gut Project (AGP) were analysed. The tendency score matching (PSM) method was used to match in a 1:1 manner to control for confounding factors age, gender, body mass index (BMI), and country. A total of 524 participants including 262 patients with constipation and 262 healthy controls were included in this analysis. The richness and evenness of the gut microbiota in the constipation group were significantly lower than those in the control group. The dominant genera in the constipation group include Escherichia_Shigella, Pseudomonas, and Citrobacter. The dominant genera in the control group include Faecalibacterium, Prevotella, Roseburia, Clostridium_XlVa, and Blautia. The abundance of three butyrate production-related pathways were significantly higher in the constipation group than in the control groups. There was no significant difference in the diversity and gut microbiota composition in patients with constipation at different ages. In conclusion, patients with constipation showed gut microbiota and butyrate metabolism dysbiosis. This dysbiosis might provide a reference for the diagnosis and clinical therapy of diseases.

便秘患者粪便微生物群组成的改变:美国肠道项目的证据。
目前关于便秘患者与健康对照组肠道微生物群组成差异的信息还很有限。在此,我们对公开的美国肠道项目(AGP)中微生物群的粪便 16S rRNA 快速序列数据进行了分析。采用倾向得分匹配法(PSM)进行1:1匹配,以控制年龄、性别、体重指数(BMI)和国家等混杂因素。本次分析共纳入了 524 名参与者,包括 262 名便秘患者和 262 名健康对照者。便秘组肠道微生物群的丰富度和均匀度明显低于对照组。便秘组的优势菌属包括志贺氏菌、假单胞菌和柠檬酸杆菌。对照组的优势菌属包括粪杆菌、普雷沃特氏菌、罗斯布氏菌、XlVa梭菌和布劳氏菌。与对照组相比,便秘组中三种与丁酸生产相关的途径的丰度明显较高。不同年龄段的便秘患者肠道微生物群的多样性和组成无明显差异。总之,便秘患者表现出肠道微生物群和丁酸盐代谢紊乱。这种菌群失调可为疾病的诊断和临床治疗提供参考。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Beneficial microbes
Beneficial microbes MICROBIOLOGY-NUTRITION & DIETETICS
CiteScore
7.90
自引率
1.90%
发文量
53
审稿时长
>12 weeks
期刊介绍: Beneficial Microbes is a peer-reviewed scientific journal with a specific area of focus: the promotion of the science of microbes beneficial to the health and wellbeing of man and animal. The journal contains original research papers and critical reviews in all areas dealing with beneficial microbes in both the small and large intestine, together with opinions, a calendar of forthcoming beneficial microbes-related events and book reviews. The journal takes a multidisciplinary approach and focuses on a broad spectrum of issues, including safety aspects of pro- & prebiotics, regulatory aspects, mechanisms of action, health benefits for the host, optimal production processes, screening methods, (meta)genomics, proteomics and metabolomics, host and bacterial physiology, application, and role in health and disease in man and animal. Beneficial Microbes is intended to serve the needs of researchers and professionals from the scientific community and industry, as well as those of policy makers and regulators. The journal will have five major sections: * Food, nutrition and health * Animal nutrition * Processing and application * Regulatory & safety aspects * Medical & health applications In these sections, topics dealt with by Beneficial Microbes include: * Worldwide safety and regulatory issues * Human and animal nutrition and health effects * Latest discoveries in mechanistic studies and screening methods to unravel mode of action * Host physiology related to allergy, inflammation, obesity, etc. * Trends in application of (meta)genomics, proteomics and metabolomics * New developments in how processing optimizes pro- & prebiotics for application * Bacterial physiology related to health benefits
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信